메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic

WUXI, China, Jan. 13, 2026 -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi –Drug Product Facility 5 (DP5) and Drug Product Packaging Center (DPPC) – have received GMP certifications from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for commercial manufacturing of an ophthalmic biologic. WuXi Biologics delivers end-to-end manufacturing services for this ophthalmic biologic, covering both drug substance and drug product. During the four-day
- 김갑성 기자
- 2026-01-13 11:07
ETO Markets Strengthens Global Compliance Framework with Mauritius FSC License

SYDNEY, Jan. 13, 2026 -- ETO Markets, a globally recognized trading platform, has secured a financial services license from the Financial Services Commission of Mauritius (Mauritius FSC, License No. C119023893). This regulatory authorization reinforces the company's commitment to transparency, investor protection, and high operational standards across international markets. A Milestone in Global Compliance The Mauritius FSC license represents a meaningful enhancement to ETO Markets' global regulatory framework, strengthening its position as a trusted international financ
- 황정호 기자
- 2026-01-13 11:06
Schaeffler appoints Maximilian Fiedler as Regional Chief Executive Officer Asia/Pacific

[ 메디채널 황정호 기자 ] HERZOGENAURACH, Germany and SINGAPORE, Jan. 13, 2026 -- Schaeffler, the leading motion technology company, announced the appointment of Maximilian Fiedler (38) as Regional CEO, Asia/Pacific, effective 1 January 2026. In this role, he will also be part of the Executive Board of Schaeffler Group, representing the region. Mr. Fiedler has been serving as the Chief Financial Officer, Region Asia/Pacific, since 2022. In June 2025, Maximilian Fiedler assumed the position as Regional CEO Asia/Pacific on a temporary basis in addition to his role as CFO Asia/Pacific. Mr.
- 황정호 기자
- 2026-01-13 10:05
CapitaLand India Data Centre Fund to acquire 20.2% interest in three data centres for S$99.73 million

The development-focused data centre fund raised approximately S$150 million equity at first close SINGAPORE, Jan. 12, 2026 -- CapitaLand Investment Limited (CLI), a leading global real asset manager, has successfully raised approximately S$150 million equity in the first close of its CapitaLand India Data Centre Fund (CIDCF). CIDCF focuses on data centre development opportunities within India's key data centre corridors. CIDCF held a first close of approximately S$150 million anchored by a third-party global institutional investor, with a GP commitment from
- 황정호 기자
- 2026-01-13 09:00
Arcesium Opens Hong Kong Office to Support Growing APAC Client Demand

Hong Kong presence marks Arcesium's commitment to supporting investment firms across the APAC region with investment operations and data strategy HONG KONG, Jan. 13, 2026 -- Arcesium, a leading provider of investment lifecycle and data management technology for the global investment industry, today announces the expansion of its global operations with the opening of a new office in Hong Kong. Arcesium's on the ground presence in Asia allows the firm to meet growing investment industry demand for sophisticated data infrastructure and operational technology which unlocks scale i
- 황정호 기자
- 2026-01-13 09:00
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research

FREMONT, Calif., Jan. 13, 2026 -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) NULISAqpcr™ AD 5-plex Assay. This innovative solution enables simultaneous quantitative measurement of five critical blood-based biomarkers relevant to the Alzheimer's Association recommended guidelines: brain-derived phosphorylated tau 217 (BD-pTau217), neurofilament light chain (NfL), amyloid-beta 42 (Aβ42), glial fibrillary acidic protein (GFAP), and APOE4 (carr
- 김갑성 기자
- 2026-01-13 06:27
"IN SNOOKI WE TRUST" - NICOLE 'SNOOKI' POLIZZI HEADS NORTH IN NEW SERIES, CANADA SHORE

CANADA SHORE premieres January 22 with two back-to-back episodes on Paramount+ Check out the CANADA SHORE "This Season On" Trailer HERE Follow @CANADASHORE on INSTAGRAM and TIKTOK for the Latest News, Exclusive Content and more Snooki Images HEREKey Art, Promo Trailer and Cast Images HEREPhoto credit Paramount+ TORONTO, Jan. 13, 2026 -- Paramount+ announced today that the legendary JERSEY SHORE original cast member Nicole 'Snooki' Polizzi will bring her small stature and big personality to the Shore house, making several powerhouse guest appeara
- 김장윤(JASON KIM) 기자
- 2026-01-13 03:29
HCLTech Q3 FY26 revenue up 4.2% QoQ (CC) as annualized revenue crosses $15B; bookings exceptionally high at $3B

Revenue guidance raised to 4.0% - 4.5% YoY CC, services revenue guidance to 4.75%-5.25% YoY CC NEW YORK and NOIDA, India, Jan. 13, 2026 -- HCLTech (NSE: HCLTECH.NS) (BSE: HCLTECH.BO), a leading global technology company, delivered a strong performance for the quarter ended December 31, 2025, with USD revenue at $3.8 billion. The revenue in constant currency (CC) increased 4.2% QoQ and 4.8% YoY. "(We had) another standout quarter on all fronts… with a strong recovery of operating margin to 18.6%. The strong revenue momentum in the quarter has enabled us to cross $15
- 황정호 기자
- 2026-01-13 02:27
diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy

[ 메디채널 김갑성 기자 ] Expert recommendations provide crucial guidance to leverage CGM and AID during pregnancy. SAN FRANCISCO, Jan. 13, 2026 -- The diaTribe Foundation announces the publication of the first international consensus statement on the use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) during pregnancy. Published in The Lancet Diabetes & Endocrinology, the document aims to standardize care, improve outcomes, and ease the daily burden of managing type 1 (T1D), type 2 (T2D), and gestational diabetes (GDM) during pregnancy. Managing diabetes
- 김갑성 기자
- 2026-01-13 01:22
NVISAGE Technologies to Present Complete Golf Launch Monitor Lineup at PGA Show 2026

CHICAGO, Jan. 13, 2026 -- NVISAGE Technologies, a U.S.-based leader in next-generation golf technology, will showcase its full portfolio of golf launch monitors at PGA Show 2026, the industry's most influential golf trade event. The exhibition will take place from January 21–23, 2026, in Orlando, Florida, where attendees can explore NVISAGE's innovative golf technology at booth 1515. Founded in 2023 and headquartered in Illinois, NVISAGE Technologies has quickly established itself as a trusted name in indoor and outdoor golf solutions. The company's mission is to make a
- 황정호 기자
- 2026-01-13 00:00

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2026-01-15_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 15일 14시 00분